PRECIGEN (PGEN) CFO receives 40,293 RSUs and converts them into common stock

Rhea-AI Filing Summary

PRECIGEN, INC. Chief Financial Officer Harry Thomasian Jr. received a grant of 40,293 restricted stock units on March 18, 2026. Each RSU represents a contingent right to receive one share of Precigen common stock and the RSUs vested immediately upon grant. He then exercised the RSUs into 40,293 shares of common stock at a conversion price of $0.00 per share, bringing his directly held common stock position to 508,919 shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Thomasian Harry Jr.

(Last) (First) (Middle)

20374 SENECA MEADOWS PARKWAY

(Street)

GERMANTOWN MARYLAND 20876

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PRECIGEN, INC. [ PGEN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/18/2026		M		40,293	A	(1)	508,919	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	03/18/2026		A		40,293		(2)	(2)	Common Stock	40,293	$0	40,293	D
Restricted Stock Units	(1)	03/18/2026		M			40,293	(2)	(2)	Common Stock	40,293	$0	0	D

Explanation of Responses:

1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.

2. The RSUs vested immediately upon the grant date.

	/s/ Harry Thomasian, Jr., by Donald P. Lehr, as attorney-in-fact	03/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did PRECIGEN (PGEN) report for its CFO?

PRECIGEN reported that CFO Harry Thomasian Jr. received and immediately vested 40,293 restricted stock units, then exercised them into 40,293 shares of common stock. The transactions were recorded at a conversion price of $0.00 per share as equity compensation.

How many PRECIGEN (PGEN) RSUs were granted to the CFO in this Form 4?

The Form 4 shows a grant of 40,293 restricted stock units to CFO Harry Thomasian Jr. on March 18, 2026. Each RSU represents a contingent right to receive one share of PRECIGEN common stock, and all of these RSUs vested immediately on the grant date.

Did PRECIGEN (PGEN) CFO buy or sell shares in the open market?

The Form 4 does not report any open-market purchases or sales. It shows a grant of restricted stock units and their exercise into common stock at $0.00 per share, which are compensation-related equity transactions rather than market trades on an exchange.

How many PRECIGEN (PGEN) common shares does the CFO hold after this filing?

After exercising 40,293 restricted stock units into common stock, CFO Harry Thomasian Jr. directly holds 508,919 shares of PRECIGEN common stock. This post-transaction total is reported explicitly as the number of shares owned following the derivative exercise.

What do the PRECIGEN (PGEN) RSU footnotes in this Form 4 explain?

The footnotes explain that each restricted stock unit represents a contingent right to receive one share of PRECIGEN common stock and that the RSUs vested immediately on the grant date. This clarifies both the one-for-one conversion and the instant vesting terms.

Were any restricted stock units left outstanding for PRECIGEN (PGEN) CFO after the exercise?

The filing shows that 40,293 RSUs were granted and then fully exercised, leaving zero RSUs reported as remaining afterward. The derivativeSummary section is empty, indicating no additional derivative positions are visible for this reporting person in this particular Form 4.